Holen Sie sich die Stockscreener-App
0.4706
0.08%
-0.0004
Handel nachbörslich:
2.66
2.1894
+465.24%
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
38.06%
1.15
|
0.833 | 2.297 | 2.122 | 2.314 |
| Operating Income/Loss |
21.69%
-1.513
|
-1.932 | -3.604 | -3.906 | -3.091 |
| Nonoperating Income/Loss |
93.08%
0.08
|
1.156 | 0.193 | 0.196 | 0.825 |
| Income/Loss From Continuing Operations Before Tax |
79.12%
-1.433
|
-0.80 | -3.411 | -3.71 | -2.266 |
| Income/Loss From Continuing Operations After Tax |
79.12%
-1.433
|
-0.80 | -3.411 | -3.71 | -2.266 |
|
Net Income/Loss
|
79.12%
-1.433
|
-0.80 | -3.411 | -3.71 | -2.266 |
| Preferred Stock Dividends And Other Adjustments |
0.085
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-0.024 | - | - | - |
| Basic Average Shares |
18.19%
2.7718
|
2.3451 | 2.2343 | 1.712 | 1.3806 |
| Diluted Average Shares |
18.19%
2.7718
|
2.3451 | 2.2343 | 1.712 | 1.3806 |
| Basic Earnings Per Share |
66.67%
-0.55
|
-0.33 | -1.53 | -2.17 | -1.64 |
| Diluted Earnings Per Share |
66.67%
-0.55
|
-0.33 | -1.53 | -2.17 | -1.64 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.085
|
- | - | - | - |
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):